# Calimmune

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/calimmune

- Industry: Biotechnology
- Headquarters: Tucson, US
- Website: www.calimmune.com
- Total disclosed funding: $16M
- Latest round: Series B (May 26, 2015)
- Investors on record: 3

## About

Founded in 2006 and based in Arizona, US, Calimmune, Inc. operates as a clinical-stage biotechnology company that develops cell-based therapies for chronic and incurable diseases.

## Funding rounds

- Series B, May 26, 2015, $16M — Alexandria Venture Investments, RA Capital Management, Translational Accelerator

## Investors

- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series B
- RA Capital Management (https://capitalatlas.ai/funds/ra-capital-management) — Series B
- Translational Accelerator (https://capitalatlas.ai/funds/translational-accelerator) — Series B